|
1
|
Ansell S, Bartlett N, Chen R, Herrera A, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Rodriguez Izquierdo A, Lossos I, Reeder C, Sher T, Choe-Juliak C, Prier K, Schwarz S, Strassz A, Alland L. INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE. Hematol Oncol 2019. [DOI: 10.1002/hon.134_2629] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- S.M. Ansell
- Hematology; Mayo Clinic; Rochester United States
| | - N.L. Bartlett
- Medical Oncology; Siteman Cancer Center, Washington University School of Medicine; St. Louis United States
| | - R.W. Chen
- Hematology & Hematopoietic Cell Transplantation; City of Hope; Duarte United States
| | - A. Herrera
- Hematology & Hematopoietic Cell Transplantation; City of Hope; Duarte United States
| | - E. Domingo-Domenech
- Clinical Hematology; Instituto Catalán de Oncología L'Hospitalet; Barcelona Spain
| | - A. Mehta
- Lymphoma Program; Hematology and Oncology, University of Alabama at Birmingham; Birmingham United States
| | - A. Forero-Torres
- Lymphoma Program; Hematology and Oncology, University of Alabama at Birmingham; Birmingham United States
| | - R. Garcia-Sanz
- Hematology; Hospital Universitario de Salamanca; Salamanca Spain
| | - P. Armand
- Medical oncology; Dana Farber Cancer Institute; Boston United States
| | - S. Devata
- Division of Hematology/Oncology; University of Michigan Rogel Cancer Center; Ann Arbor United States
| | | | - I.S. Lossos
- Hematology/oncology; University of Miami Sylvester Comprehensive Cancer Center; Miami United States
| | - C.B. Reeder
- Hematology; Mayo Clinic - Arizona; Phoenix United States
| | - T. Sher
- Hematology; Mayo Clinic - Floria; Jacksonville United States
| | - C. Choe-Juliak
- Clinical Development; Affimed, Inc.; New York United States
| | - K. Prier
- Clinical Operations; Affimed GmbH; Heidelberg Germany
| | - S.E. Schwarz
- Clinical Operations; Affimed GmbH; Heidelberg Germany
| | - A. Strassz
- Clinical Operations; Affimed GmbH; Heidelberg Germany
| | - L. Alland
- Clinical Development; Affimed, Inc.; New York United States
| |
Collapse
|